Morbifix-TZ 1.125 Injection
Marketer
Wellmark Lifesciences Private Limited
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Morbifix-TZ 1.125 Injection
Bacterix-Comb 1.125 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curtailing infection spread. Administration must be strictly under a doctor's guidance. Consistent adherence to the prescribed dosage schedule is crucial; prematurely halting treatment compromises its effectiveness. Complete the full course, even with symptom improvement. Minor side effects may include nausea, vomiting, diarrhea, or indigestion. Report any worsening side effects immediately to your physician. Seek urgent medical attention for allergic reactions (e.g., rash, itching, swelling, breathing difficulties). Inform your doctor about all current medications and pre-existing health conditions before commencing treatment. Pregnant or nursing individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Prioritize rest, a nutritious diet, and ample hydration for optimal recovery. Your doctor might order tests to monitor the medication's impact.
Primary Ingredients of Morbifix-TZ 1.125 Injection
There is no text provided to rephrase.
Uses of Morbifix-TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Morbifix-TZ 1.125 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Morbifix-TZ 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Morbifix-TZ 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Morbifix-TZ 1.125 Injection works:
Ceftriaxone and Tazobactum, the components of Morbifix-TZ 1.125 Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial defenses, thus optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Morbifix-TZ 1.125 Injection shows no adverse reactions when taken with alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Morbifix-TZ 1.125 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data from human trials, however, remain scarce.
Breast feedingCAUTION
Administering Morbifix-TZ 1.125 Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Morbifix-TZ 1.125 Injection may induce drowsiness, blurred vision, or dizziness. Driving is inadvisable should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Morbifix-TZ 1.125 Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Morbifix-TZ 1.125 Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Morbifix-TZ 1.125 Injection isn't suggested for those experiencing mild or moderate liver dysfunction.
What if you forget to take Morbifix-TZ 1.125 Injection :
Omit a dose of Morbifix-TZ 1.125 Injection? Seek your physician's advice.
Facts to Know About Morbifix-TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently